Interferon beta-1a Completed Phase 3 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00725985Oral Cladribine in Early Multiple Sclerosis (MS)
NCT00110396Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis
NCT00605215BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
NCT0073500712-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
NCT00883337A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
NCT01181115Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)